hVEGF-IN-2
Modify Date: 2024-01-10 18:52:53
hVEGF-IN-2 structure
|
Common Name | hVEGF-IN-2 | ||
|---|---|---|---|---|
| CAS Number | 186610-88-8 | Molecular Weight | 306.37 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H18N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of hVEGF-IN-2hVEGF-IN-2 (compound 19) is a selective VEGF (Flk-1) receptor tyrosine kinases (RTK) inhibitor with an IC50 value of 2.5 μM. hVEGF-IN-2 inhibits PDGF RTK activity with an IC50 value of 33.1 μM. hVEGF-IN-2 can be used for the development of RTK-specific drugs[1]. |
| Name | way-607500 |
|---|
| Description | hVEGF-IN-2 (compound 19) is a selective VEGF (Flk-1) receptor tyrosine kinases (RTK) inhibitor with an IC50 value of 2.5 μM. hVEGF-IN-2 inhibits PDGF RTK activity with an IC50 value of 33.1 μM. hVEGF-IN-2 can be used for the development of RTK-specific drugs[1]. |
|---|---|
| Related Catalog | |
| Target |
VEGFR1:2.5 μM (IC50) PDGF:33.1 μM (IC50) |
| In Vitro | hVEGF-IN-2 (0-100 μM) shows the inhibitory activities to particular RTKs at the cellular level with IC50 values of 2.5, 33.1, ＞100, ＞100 and ＞100 nM for VEGF, PDGF, EGF, HER-2 and IGF-1, respectively[1]. |
| Molecular Formula | C19H18N2O2 |
|---|---|
| Molecular Weight | 306.37 |